EuMentis Announces the First Closing of a Targeted $40M Series B Financing
15 Feb 2023 //
GLOBENEWSWIRE
ImmunityBio, Codagenix and EuMentis raise funds, while a biotech SPAC dissolves
15 Feb 2023 //
ENDPTS
EuMentis Receives $3M Award from US DoD to Advance NMDA Receptor Antagonist
08 Feb 2023 //
GLOBENEWSWIRE
Biotech receives award from DOD; Regulators accept Appili Therapeutics` NDA
08 Feb 2023 //
ENDPTS